Top Markets
Coin of the day
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A.

PHXM
Classement en actions #39465
PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating... PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes eryaspase, currently undergoing Phase 3 clinical trials for advanced pancreatic cancer and Phase 2 studies for treating triple-negative breast cancer and acute lymphoblastic leukemia after initial treatments. Additionally, PHAXIAM is advancing a range of phage therapies designed to combat hazardous, drug-resistant bacteria. These pathogens, such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, are responsible for over two-thirds of all resistant infections acquired in hospital settings. Established in 2004, the company was previously known as ERYTECH Pharma S.A. before adopting the name PHAXIAM Therapeutics S.A. in June 2023. Its corporate headquarters are located in Lyon, France.
Prix de l'action
$0.11725176
Dernière synchronisation: 2025-07-14
Capitalisation boursière
$481.50K
Changement (1 jour)
-0.20%
Changement (1 an)
0.00%
Pays
FR
Échange PHAXIAM Therapeutics S.A. (PHXM)

Catégorie

Le prix PHXM avec la capitalisation boursière de B
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.
PHXM
$0.11725176
Capitalisation boursière de PHAXIAM Therapeutics S.A.(PHXM)
Capitalisation boursière: $481.50K
En August 2026, PHAXIAM Therapeutics S.A. a une capitalisation boursière de $481.50K. Cela fait de PHAXIAM Therapeutics S.A. la 39465th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de PHAXIAM Therapeutics S.A. du 2013 au 2026
PHXM par rapport au top 5 des plus populaires stocks
Prix pour PHXM L’actif B La capitalisation boursière de B Résultats
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.
$1,331,898 $481.50K
$5.470T +1,135,929,987.20%
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.
$1,087,785 $481.50K
$4.467T +927,734,708.21%
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.
$1,016,513 $481.50K
$4.174T +866,949,039.34%
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.
$901,013 $481.50K
$3.700T +768,443,105.15%
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.
$695,067 $481.50K
$2.854T +592,798,392.88%